These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 16797605)

  • 1. Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis.
    Yamagishi S; Matsui T; Nakamura K; Takeuchi M; Imaizumi T
    Microvasc Res; 2006; 72(1-2):86-90. PubMed ID: 16797605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
    Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
    Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).
    Yamagishi S; Matsui T; Takenaka K; Nakamura K; Takeuchi M; Inoue H
    Diabetes Metab Res Rev; 2009 Mar; 25(3):266-71. PubMed ID: 19165765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pigment epithelium-derived factor (PEDF) inhibits diabetes- or advanced glycation end product (AGE)-induced platelet CD40 ligand overexpression in rats.
    Yamagishi S; Matsui T; Ueda S; Takeuchi M
    Int J Cardiol; 2010 Oct; 144(2):283-5. PubMed ID: 19237211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by advanced glycation end products (AGEs) of pigment epithelium-derived factor (PEDF) gene expression in microvascular endothelial cells.
    Yamagishi S; Matsui T; Inoue H
    Drugs Exp Clin Res; 2005; 31(5-6):227-32. PubMed ID: 16425980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation.
    Ide Y; Matsui T; Ishibashi Y; Takeuchi M; Yamagishi S
    Microvasc Res; 2010 Sep; 80(2):227-32. PubMed ID: 20381502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathy.
    Matsuoka M; Ogata N; Minamino K; Matsumura M
    Mol Vis; 2007 Jun; 13():1058-65. PubMed ID: 17653050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability.
    Sheikpranbabu S; Haribalaganesh R; Lee KJ; Gurunathan S
    Biochimie; 2010 Aug; 92(8):1040-51. PubMed ID: 20470857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
    J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes.
    Amano S; Yamagishi S; Inagaki Y; Nakamura K; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2005 Jan; 69(1-2):45-55. PubMed ID: 15797260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat.
    Ma P; Luo Y; Zhu X; Ma H; Hu J; Tang S
    Biochem Biophys Res Commun; 2009 Mar; 380(2):402-6. PubMed ID: 19250642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants.
    Mamputu JC; Renier G
    J Leukoc Biol; 2004 Jun; 75(6):1062-9. PubMed ID: 15020646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pigment epithelium-derived factor is a pericyte mitogen secreted by microvascular endothelial cells: possible participation of angiotensin II-elicited PEDF downregulation in diabetic retinopathy.
    Yamagishi S; Matsui T; Nakamura K; Inoue H
    Int J Tissue React; 2005; 27(4):197-202. PubMed ID: 16440585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of angiotensin II in retinal leukostasis in the diabetic rat.
    Chen P; Scicli GM; Guo M; Fenstermacher JD; Dahl D; Edwards PA; Scicli AG
    Exp Eye Res; 2006 Nov; 83(5):1041-51. PubMed ID: 16822509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF.
    Yamagishi S; Nakamura K; Ueda S; Kato S; Imaizumi T
    Cell Tissue Res; 2005 Jun; 320(3):437-45. PubMed ID: 15846509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.
    Wang JJ; Zhang SX; Mott R; Chen Y; Knapp RR; Cao W; Ma JX
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1166-73. PubMed ID: 18322021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression.
    Yamagishi S; Nakamura K; Matsui T; Inagaki Y; Takenaka K; Jinnouchi Y; Yoshida Y; Matsuura T; Narama I; Motomiya Y; Takeuchi M; Inoue H; Yoshimura A; Bucala R; Imaizumi T
    J Biol Chem; 2006 Jul; 281(29):20213-20. PubMed ID: 16707486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
    Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of pigment epithelium-derived factor in the retina of a rat model of type 2 diabetes.
    Matsuoka M; Ogata N; Minamino K; Higuchi A; Matsumura M
    Exp Eye Res; 2006 Jan; 82(1):172-8. PubMed ID: 16054135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.